Overview
Comparison nafamostat and low molecular weight heparin among dialysis patients
Eligibility
Inclusion Criteria:
- platelet below 10k PTT above 60 second INR above 20 patient with bleeding (epistaxis, orbital bleeding, hematuria) recent brain hemorrhage (within 6 months) receiving anticoagulant therapy (coumadin or NOAC) dual antiplatelet agent users received major surgery within one month
Exclusion Criteria:
- cancer liver cirrhosis pregnancy drug allergy current bleeding on major organ (brain, gastrointestinal)